Jizhong Lou

Jizhong Lou

Auto-generated profile, based on publicly available information

Jizhong Lou

State Key Laboratory of Epigenetic Regulation and Intervention, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 April 2020 in Science China Life Sciences
Verified
Journal Article
Closed access
PDF file
HZHong Zhang
Hong Zhang
XJXiong Ji
Xiong Ji
PLPilong Li
Pilong Li
CLCong Liu
Cong Liu
JLJizhong Lou
Jizhong Lou
XZXueliang Zhu
Xueliang Zhu

18 September 2019 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
CZCheng Zhu
Cheng Zhu
WCWei Chen
Wei Chen
JLJizhong Lou
Jizhong Lou
WRWilliam Rittase
William Rittase
KLKaitao Li
Kaitao Li

8 September 2020 in Cell Research
Verified
Journal Article
Closed access
PDF file
HCHui Chen
Hui Chen
YCYang Cui
Yang Cui
XHXuling Han
Xuling Han
WHWei Hu
Wei Hu
MSMin Sun
Min Sun
JLJizhong Lou
Jizhong Lou

1 March 2019 in Molecular Cell
Verified
Journal Article
Closed access
PWPeng Wu
Peng Wu
TZTongtong Zhang
Tongtong Zhang
BLBaoyu Liu
Baoyu Liu
PFPanyu Fei
Panyu Fei
LCLei Cui
Lei Cui
JLJizhong Lou
Jizhong Lou

4 January 2022 in Molecular Cancer
Verified
Journal Article
Open access
PDF file
YCYiran Chen
Yiran Chen
LLLi Li
Li Li
JLJie Lan
Jie Lan
YCYang Cui
Yang Cui
XRXiaosong Rao
Xiaosong Rao
JLJun Liang
Jun Liang
Background: Hepatocellular carcinoma (HCC) is among the most common forms of cancer and is associated with poor patient outcomes. The emergence of therapeutic resistance has hampered the efficacy of targeted treatments employed to treat HCC patients to date. In this study, we conducted a series of CRISPR/Cas9 screens to identify genes associated with synthetic lethality capable of improving HCC patient clinical responses. Methods: CRISPR-based loss-of-function genetic screens were used to target 18,053 protein-coding genes in HCC cells to identify chemotherapy-related synthetic lethal genes in these cells. Synergistic effects were analyzed through in vitro and in vivo analyses, while related mechanisms were explored through RNA-seq and metabolomics analyses. Potential inhibitors of identified genetic targets were selected through high-throughput virtual screening. Results: The inhibition of phosphoseryl-tRNA kinase (PSTK) was found to increase HCC cell sensitivity to chemotherapeutic treatment. PSTK was associated with the suppression of chemotherapy-induced ferroptosis in HCC cells, and the depletion of PSTK resulted in the inactivation of glutathione peroxidative 4 (GPX4) and the disruption of glutathione (GSH) metabolism owing to the inhibition of selenocysteine and cysteine synthesis, thus enhancing the induction of ferroptosis upon targeted chemotherapeutic treatment. Punicalin, an agent used to treat hepatitis B virus (HBV), was identified as a possible PSTK inhibitor that exhibited synergistic efficacy when applied together with Sorafenib to treat HCC in vitro and in vivo. Conclusions: These results highlight a key role for PSTK as a mediator of resistance to targeted therapeutic treatment in HCC cells that functions by suppressing ferroptotic induction. PSTK inhibitors may thus represent ideal candidates for overcoming drug resistance in HCC.

2 March 2022 in Journal of Biological Chemistry
Verified
Journal Article
Open access
ZWZheng Wang
Zheng Wang
JLJizhong Lou
Jizhong Lou
HZHong Zhang
Hong Zhang
Intracellular spaces are partitioned into separate compartments to ensure that numerous biochemical reactions and cellular functions take place in a spatiotemporally controlled manner. Biomacromolecules including proteins and RNAs undergo liquid–liquid phase separation and subsequent phase transition to form biological condensates with diverse material states. The material/physical properties of biological condensates are crucial for fulfilling their distinct physiological functions, and abnormal material properties can cause deleterious effects under pathological conditions. Here, we review recent studies showing the role of the material properties of biological condensates in their physiological functions. We also summarize several classic methods as well as newly emerging techniques for characterization and/or measurement of the material properties of biological condensates.